Lv4
448 积分 2024-03-15 加入
Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial
2天前
已关闭
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
2天前
已完结
急性阑尾炎临床诊治研究进展
18天前
已完结
LBP-013 A phase Ib multiple dose ascending study of HH-006 in treatmentnaïve participants with chronic hepatitis B virus infection
25天前
已关闭
急性胰腺炎病情早期评估与预后的研究进展
1个月前
已完结
急性胰腺炎并发胆道系统疾病的诊治进展
1个月前
已完结
中国肝硬化临床诊治共识意见
1个月前
已完结
Comprehensive pharmacovigilance analysis of lebrikizumab: a real-world safety assessment based on the FDA Adverse Event Reporting System (FAERS) database
1个月前
已完结
严重过敏反应诊断和临床管理专家共识（2025）
1个月前
已完结
First-in-Human, Phase 1 Study of CM512, a TSLP/IL-13 Bispecific Antibody, in Healthy Volunteers: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity
1个月前
已关闭
皖公网安备34019202002308
